We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 122

Data protection: defining innovative drug in Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 22 2013

Canada amended its Data Protection Regulations in 2006 to provide protection for innovative drugs in a second attempt to implement Canada's 1994

Aventis v. Pharmascience; motion to set aside a previous order of prohibition; 2009 FC 915; ramipril; September 15, 2009

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 30 2009

Pharmascience had previously sent an Notice of Allegation (NOA) with respect to a patent to Aventis, resulting in a full hearing and appeal, concluding with an order of prohibition

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing

Apotex v. Sanofi; interlocutory motion re: affidavits of documents; clopidogrel

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

Both parties brought motions for further and better affidavits of documents

Apotex v AstraZeneca; motion to strike parts of a statement of claim in a Section 8 proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 15 2007

The Court dismissed the appeal of a Prothonotary's decision refusing to strike parts of the Statement of Claim

AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply

Recent cases

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 17 2008

Pfizer brought a motion for production of information relating to Pharmascience's product in response to Pharmascience's motion to dismiss the proceeding on the basis of non-infringement and on the basis that the patent was not eligible for inclusion on the Patent Register

Apotex v. Servier

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 4 2009

The defendant brought a motion to strike portions of the generic company's claim for s. 8 damages

Pfizer v. Ratiopharm; motion to set aside a final decision of the Court of Appeal in the 55.2 proceeding; December 18, 2007 - amlodipine besylate

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 17 2008

Ratiopharm brought a motion to set aside the decision of the Court of Appeal granting prohibition in response to a 55.2 application